One-Year Outcomes with Use of Anti-T-Lymphocyte Globulin in Patients Undergoing Kidney Transplantation: Results from a Prospective, Multicentric, Observational Study from India

INTRODUCTION: Large-scale Indian data on the use of anti-T-lymphocyte globulin (ATLG) (Grafalon(®)) as induction therapy in kidney transplantation (KT) patients is lacking. The aim of this study was to determine the 1-year patient and graft survival outcomes with the use of ATLG as induction regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gang, Sishir, Gulati, Sanjeev, Bhalla, Anil K., Varma, Prem P., Bansal, Ravi, Abraham, Abi, Ray, Deepak S., John, Mammen M., Bansal, Shyam B., Sharma, Raj K., Vishwanath, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464724/
https://www.ncbi.nlm.nih.gov/pubmed/35817945
http://dx.doi.org/10.1007/s12325-022-02225-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464724/
https://www.ncbi.nlm.nih.gov/pubmed/35817945
http://dx.doi.org/10.1007/s12325-022-02225-y

Ejemplares similares